EZH2, the catalytic subunit of PRC2, is involved in cell proliferation, cell differentiation and apoptosis [31–35], and EZH2 deregulation participates not only in tumorigenesis, tumor progression, and tumor metastasis but alsoin tumor microenvironment modulation. Here, EZH2 is linked to neoplasm.